Special Issue "Obesity, Diabetes and Metabolic Syndrome"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383).
Deadline for manuscript submissions: closed (28 February 2014)
Prof. Dr. Paul Huang
Harvard Medical School, Director, MGH Cardiac Metabolic Syndrome Program, Cardiovascular Research Center and Harvard Stem Cell Institute, Massachusetts General Hospital, 149 Thirteenth Street, Charlestown, MA 02129, USA
Phone: +617 724 9849
Fax: +617 726 5806
Interests: nitric oxide; cardiovascular disease; metabolic syndrome; diabetes mellitus; obesity; vascular function; vascular biology; endothelium; animal models of human disease; translational research; genomics; metabolomics
Obesity and diabetes mellitus are increasing at rapid rates in the population worldwide, leading to many health problems. Obesity and diabetes increase the risk for cardiovascular disease, along with hypertension, hyperlipidemia, smoking, sedentary lifestyle, and genetics/family history. Many people who have type 2 diabetes are overweight, and there are clear pathophysiologic links between obesity, insulin resistance, and diabetes. In fact, the commonality of excess weight, hyperglycemia, hypertension, and atherogenic dyslipidemia has led to the concept of the metabolic syndrome.
This Special Issue of the Journal of Clinical Medicine will cover the following important aspects of obesity, diabetes, and the metabolic syndrome:
- Lifestyle interventions for obesity and diabetes
- Medical and surgical treatments for obesity
- Effect of gastric bypass surgery on insulin sensitivity
- Involvement of white and brown fat in human disease
- Mechanisms by which diabetes increases cardiovascular disease
- Effects of glycemic control on microvascular (renal and retina) and macrovascular (CAD and stroke) disease
- Relationships between diabetes and hyperlipidemia
- Management of prediabetes
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- body mass index (BMI)
- metabolic syndrome
- insulin resistance
- white adipose tissue (WAT)
- brown adipose tissue (BAT)
- brown fat
- glycemic control
- diabetic retinopathy
- diabetic nephropathy